Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease

被引:65
|
作者
Ahlskog, JE [1 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
关键词
Parkinson's disease; oxidative stress; dopamine; levodopa;
D O I
10.1002/mds.20362
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Oxidative stress is well documented in Parkinson's disease (PD) and has been attributed to dopamine oxidative metabolism. However, evidence of oxidative stress is found in a variety of neurodegenerative disorders, suggesting that more general factors are responsible or that cytodestructive processes secondarily generate oxyradical products. Increasing evidence points away from dopamine metabolism as an important contributor to PD neurodegeneration. Predictions front the dopamine oxidative stress hypothesis of PD reveal multiple inconsistencies. Although the clinical and therapeutic importance of the nigrostriatal dopaminergic system is undeniable, PD neuropathology is much more widespread. (c) 2004 Movement Disorder Society.
引用
收藏
页码:271 / 282
页数:12
相关论文
共 50 条
  • [41] Role of dopamine agonists in Parkinson's disease therapy
    Woitalla, D.
    Buhmann, C.
    Hilker-Roggendorf, R.
    Hoeglinger, G.
    Koschel, J.
    Mueller, T.
    Weise, D.
    JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (06) : 863 - 873
  • [42] Dopamine Therapy and the Regulation of Oxidative Stress and Mitochondrial DNA Copy Number in Patients with Parkinson's Disease
    Chen, Shih-Hsuan
    Kuo, Chung-Wen
    Lin, Tsu-Kung
    Tsai, Meng-Han
    Liou, Chia-Wei
    ANTIOXIDANTS, 2020, 9 (11) : 1 - 12
  • [43] Detection of immunological factors, dopamine level and oxidative stress as a peripheral blood markers in Parkinson's disease
    Vellingiri, B.
    Meyyazhagan, A.
    Balasubramanian, B. K.
    Shanmugam, S.
    Subramaniam, M. D.
    Shahnaz, D. N.
    Keshavarao, S.
    MOVEMENT DISORDERS, 2014, 29 : S64 - S64
  • [44] Immunological markers, dopamine level and oxidative stress markers in Parkinson's disease patients in South India
    Mohanadevi, Subramaniam
    Balamuralikrishnan, Balasubramanian
    Sureshkumar, Shanmugam
    Karthickkumar, Alagamuthu
    Iyer, Mahalaxmi
    Jayalakshmi, Ramalingam
    Sasikala, Keshavarao
    Balachandar, Vellingiri
    MOVEMENT DISORDERS, 2014, 29 : S83 - S84
  • [45] The effect of dopamine on in vitro methemoglobin formation in erythrocytes of patients with Parkinson’s disease under oxidative stress
    Makletsova M.G.
    Fedorova T.N.
    Poleschuk V.V.
    Rikhireva G.T.
    Biophysics, 2017, 62 (2) : 247 - 251
  • [46] Parkinson's disease: oxidative stress and therapeutic approaches
    Surendran, Sankar
    Rajasankar, Srinivasagam
    NEUROLOGICAL SCIENCES, 2010, 31 (05) : 531 - 540
  • [47] Oxidative stress and cellular pathologies in Parkinson’s disease
    Lesly Puspita
    Sun Young Chung
    Jae-won Shim
    Molecular Brain, 10
  • [48] Oxidative stress and cellular pathologies in Parkinson's disease
    Puspita, Lesly
    Chung, Sun Young
    Shim, Jae-won
    MOLECULAR BRAIN, 2017, 10
  • [49] Oxidative stress and antioxidant therapy in Parkinson's disease
    Ebadi, M
    Srinivasan, SK
    Baxi, MD
    PROGRESS IN NEUROBIOLOGY, 1996, 48 (01) : 1 - 19
  • [50] Mitochondrial dysfunction and oxidative stress in Parkinson's disease
    Subramaniam, Sudhakar Raja
    Chesselet, Marie-Francoise
    PROGRESS IN NEUROBIOLOGY, 2013, 106 : 17 - 32